Form 4 for AXGN Axogen, Inc.
Accepted 2024-09-17 00:00:00 ET · period of report 2024-09-16 · accession 0000805928-24-000131 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-17 | 2024-09-16 | AXGN | THOMAS PAUL | Dir | A - Grant | — | +2,875 | 34.9K | +9% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-16 | A | A | 2,875 | — | 34,927 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock in connection with his appointment as Chairman of the Board of Directors. |